Sharps Technology and Jupiter Exchange Announce Staking Partnership to Accelerate Solana Adoption

Written by Emily J. Thompson, Senior Investment Analyst

STSS-8.62%

Source: PRnewswire

Updated: Sep 23 2025

0mins

Source: PRnewswire

Partnership Announcement: Sharps Technology, Inc. has formed a strategic partnership with Jupiter Exchange to utilize Jupiter's staking infrastructure as part of its digital asset treasury strategy, focusing on the Solana blockchain.
Investment and Goals: STSS plans to stake a portion of its SOL assets into Jupiter's validator and JupSOL platform, aiming to earn staking yields and enhance liquidity within the Solana ecosystem, while also supporting the network's validation and economic security.

Get Free Real-Time Notifications for Any Stock

Monitor tickers like STSS with instant alerts to capture every critical market movement.

STSS

$2.12+Infinity%1D

Analyst Views on STSS

About STSS

Sharps Technology, Inc. is a medical device and pharmaceutical packaging company. The Company is engaged in offering patented smart-safety syringe products to the healthcare industry. The Company's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. It Sharps Securegard and Sologard safety syringe product lines incorporate both active and passive safety features and have been designed to address the primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. It also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. It has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

GET FREE REAL TIME NOTIFICATIONS

Stock Monitor for STSS?

Get Started Free

FREE STOCK RECOMMENDATIONS DAILY

Stock Bullish Tomorrow

Get Started Free

70% BACKTESTED ACCURACY!

Should I Buy STSS?

Get Started Free

Sharps Technology and Jupiter Exchange Announce Staking Partnership to Accelerate Solana Adoption

Get Free Real-Time Notifications for Any Stock

Analyst Views on STSS

About STSS

About the author

Top News

Oil Firms Cautious on Venezuela Investment Push

GM Reports $7.1 Billion Charge Amid EV Shift

Stock Market Wraps 2025 with Double-Digit Gains

Novo Nordisk's Weight-Loss Pill Approval: Key Impacts

Related Articles

Sohu to Report Q4 and FY 2025 Results on February 9, 2026

Sohu to Report Q4 and FY 2025 Results on February 9, 2026

Biotech Surge Post-Market: Inspira, MediciNova, and DiaMedica Therapeutics Among Top Performers

Sharps Technology to Enhance Solana Treasury Approach in Partnership with Coinbase

Sigh Up to Get Intellectia Insights

How did the company's recent strategic decisions impact its latest financial performance?

Can you explain the factors behind the recent changes in the company's stock price?

What are the expected impacts of current market trends on the company's future growth?

Based on the latest earnings report, what are the company's forecasted revenues for the next quarter?

How does the company's performance compare to its main competitors in the same sector?

People Also Watch